Summary
Overview
Work History
Education
Skills
Websites
Languages
Timeline
Generic

Norman Goodacre

Oakland,CA

Summary

Architecting the intersection of structural biology and generative AI. I leverage decades of expertise in protein-protein interactions as well as single cell modeling to build first-principles ML models for therapeutic discovery and, ultimately, synthetic biology.

Overview

11
11
years of professional experience

Work History

Principal Bioinformatics Scientist

Xaira Therapeutics
04.2024 - Current
  • Architected machine learning workflows for generative protein modeling and structure prediction in a therapeutic discovery setting.
  • Integrated generative ML approaches with molecular dynamics simulations to explore protein conformational landscapes for the majority of drug targets
  • Led synthetic training data generation and model distillation efforts on difficult biological targets.
  • Contributed expertise in single-cell modeling for virtual cell initiative
  • Managed team of two engineers and one molecular dynamics scientist

Principal Bioinformatics Scientist

Orion Biomedicines (later Xaira Therapeutics)
10.2023 - 04.2024
  • Helped establish machine learning infrastructure and modeling strategies during early company formation.
  • Developed workflows integrating protein modeling systems with internal discovery pipelines.
  • Collaborated with ML researchers and computational scientists to evaluate emerging modeling approaches for therapeutic design.

Principal Bioinformatics Scientist

Interline Therapeutics
11.2021 - 10.2023
  • Designed computational systems for modeling protein interaction networks associated with disease genetics.
  • Built scalable pipelines for protein complex modeling, structural prediction, and interaction analysis.
  • Applied ML-enabled structural modeling approaches to problems such as short linear interaction motifs (SLiMs) and E3 ligase targeting.

Senior Data Scientist / Data Scientist

3T Biosciences
06.2018 - 11.2021
  • Built entire computational infrastructure supporting an early-stage TCR-T immunotherapy platform.
  • Developed pipelines spanning yeast display screening, protein interaction prediction, NGS-based protein engineering workflows, and single-cell RNA-seq analysis.
  • Integrated experimental and computational datasets to guide therapeutic discovery programs.
  • Was essential "gatekeeper" of all computational processes and data

ORISE Postdoctoral Fellow

U.S. Food and Drug Administration (FDA)
05.2015 - 05.2018
  • Developed the Reference Viral Database (rVDB) to improve detection of viral contaminants in biologics manufacturing.
  • Designed sequence models for identifying previously unannotated endogenous retroviral elements.
  • Created computational tools used in regulatory evaluation of vaccine production systems.

Education

PhD Bioinformatics - Biochemistry / Bioinformatics

Georgetown University
Washington, DC
2014

MPhil Computational Biology -

University of Cambridge
Cambridge, UK
2007

BS Biology With Biotech Concentration -

George Mason University
Fairfax, VA
2005

Skills

  • Extremely creative and resourceful veteran of SF tech world (~8 years) with a passion for trailblazing work, driven by curiosity and exploration
  • Machine Learning Architecture for Biology: model selection, generative protein modeling, training data strategy and evaluation
  • ML Approaches: transformers / protein language models, diffusion and flow-based generative models, graph neural networks, structure prediction systems
  • Computational Infrastructure: Python, Nextflow, AWS / scalable compute, ML research pipelines

Languages

English (Native)
French (Advanced)
German (Advanced)

Timeline

Principal Bioinformatics Scientist

Xaira Therapeutics
04.2024 - Current

Principal Bioinformatics Scientist

Orion Biomedicines (later Xaira Therapeutics)
10.2023 - 04.2024

Principal Bioinformatics Scientist

Interline Therapeutics
11.2021 - 10.2023

Senior Data Scientist / Data Scientist

3T Biosciences
06.2018 - 11.2021

ORISE Postdoctoral Fellow

U.S. Food and Drug Administration (FDA)
05.2015 - 05.2018

PhD Bioinformatics - Biochemistry / Bioinformatics

Georgetown University

MPhil Computational Biology -

University of Cambridge

BS Biology With Biotech Concentration -

George Mason University
Norman Goodacre